Minnesota recalls
3,519 federal recalls affecting Minnesota in the last 12 months - 156 Minnesota-specific plus 3,363 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-04-22FDA-DevicePhilipsClass IINationwideContact Philips about AneurysmFlow software update
Philips AneurysmFlow is software used by doctors to help evaluate aneurysm treatment with flow diverter stents. The software's Mean Aneurysm Flow Amplitude (MAFA) ratio does not reliably predict whether the aneurysm is successfully closed, but doctors may be using it to make treatment decisions based on the user manual.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B Braun hemodialysis bloodlines Model B3-4630M4705
B Braun Medical Inc is recalling specific hemodialysis bloodline tubing (Model B3-4630M4705) because small air bubbles can accumulate in the arterial line when blood gases stick to the tubing under negative pressure. This could affect dialysis treatment safety. The recall affects units manufactured since August 5, 2025.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun hemodialysis bloodlines model B3-3632M3705
B. Braun Medical Inc is recalling specific hemodialysis bloodline tubing because small air bubbles can accumulate in the arterial line during dialysis treatment. This happens when blood gases stick to the tubing when negative pressure is applied. The affected units were manufactured on or after August 1, 2025.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun StreamLine Bloodline tubing
B. Braun Medical Inc is recalling certain hemodialysis bloodlines (model SL-2000M2095L) because small air bubbles can collect in the arterial line when the tubing is under negative pressure. This happens because blood gases stick to the inside of the tubing. No injuries have been reported.
- 2026-04-22FDA-DeviceB. BraunClass INationwideB. Braun Hemodialysis Bloodlines, STREAMLINE FRESENIUS FOR DAVITA. Model Number: SL-2000M2095DA.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
- 2026-04-22FDA-DeviceB. BraunClass INationwideB. Braun Hemodialysis Bloodlines, STREAMLINE BLOODLINE SET FOR DIALOG. Model Number: SL-2010M2096
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
- 2026-04-22FDA-DeviceB. BraunClass INationwideStop using B. Braun STREAMLINE BLOODLINE SET
B. Braun Medical Inc is recalling STREAMLINE BLOODLINE SET FOR DIALOG DR. (Model SL-2010M2096A) due to a potential risk of small air bubbles accumulating in the arterial line during hemodialysis treatment. This happens when blood gases stick to the tubing under negative pressure, which could affect treatment safety. The recall affects units manufactured on or after June 9, 2025.
- 2026-04-22FDA-DeviceInsuletClass INationwideStop using affected Omnipod 5 Pods immediately
Certain Omnipod 5 Pods from 49 specific manufacturing lots contain an internal tear in the soft cannula. This defect causes insulin to leak inside the Pod instead of being delivered to your body. In some cases, the Pod may shut down completely and stop delivering insulin, or deliver less insulin than needed.
- 2026-04-22FDA-DrugAvantorClass IIINationwideStop using Avantor Magnesium Chloride
Avantor Performance Materials has recalled Magnesium Chloride, 6-Hydrate Crystal (500G bottles, Lot 23G3161005, expiration 9/21/2027) because the product does not meet strength specifications. This bulk pharmaceutical ingredient may be less potent than labeled.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IINationwideStop using Skin Script Blemish Spot Treatment
Island Kinetics, Inc. (d.b.a. CoValence Laboratories) is recalling specific lots of Skin Script Blemish Spot Treatment because the product failed stability testing. This means the product may not maintain its intended strength or safety over time. No injuries have been reported.
- 2026-04-22FDA-DrugThe Harvard DrugClass IINationwideStop using recalled memantine hydrochloride capsules
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
- 2026-04-22FDA-DrugInternational Medication SystemsClass IINationwideStop using recalled epinephrine injection
International Medication Systems Ltd. is recalling one lot of epinephrine injection due to concerns that the sterility of the product cannot be assured. The affected lot (EA038A5, expiring 08/2026) was distributed nationwide. No injuries have been reported.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Island Kinetics Essential Calming Skin Gel
Island Kinetics' Essential Calming Skin Gel containing hydrocortisone 1% may contain less active ingredient than labeled. This affects lot 4212D4 with an expiration date of 07/31/2026. The product was distributed nationwide.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Island Kinetics Hydrocortisone Balm
Island Kinetics' Skin Rehab Calming Skin Gel with Hydrocortisone 1% (Lot 4212D2, expires 07/03/2026) does not contain the correct amount of active ingredient. The product is weaker than labeled and may not work as intended for skin inflammation or itching.
- 2026-04-22FDA-DrugCoValence LaboratoriesClass IIINationwideStop using Remedy Gel hydrocortisone
Remedy Gel, a hydrocortisone 1% topical treatment distributed by glo Skin Beauty, contains less active ingredient than labeled. Affected bottles (lots 4155D2 and 4155D3, expiring 05/15/2026) may not provide the expected therapeutic effect. No injuries have been reported.
- 2026-04-22FDA-DrugNephronClass IINationwideStop using Nephron SC albuterol solution
Nephron SC is recalling albuterol sulfate inhalation solution (0.5%, 30x5 mL vials, Lot AB6001, expiring 1/15/2027) because the labels are illegible and cannot be read clearly. This makes it difficult to verify the correct dose and medication details. The recall affects 146,280 vials distributed nationwide.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro fluocinonide cream
Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to viscosity testing that showed the cream is thicker than the approved specification. This may affect how the medication spreads and absorbs. No injuries have been reported.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro Fluocinonide Cream, Lot AD76251
Taro Pharmaceuticals is recalling Fluocinonide 0.05% Cream (30g tubes, Lot AD76251, expiring 6/30/2026) because the product's thickness is outside the acceptable range. This was discovered during stability testing. The thicker-than-normal cream may affect how well it spreads and works on skin.
- 2026-04-22FDA-DrugSun PharmaceuticalClass IINationwideStop using Taro fluocinonide cream
Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to a manufacturing defect. Testing found the cream's thickness was thicker than specifications allow, which could affect how the medication works on your skin.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
The FDA inspected the manufacturing facility for QC Quality Choice menthol cough drops on August 15, 2025, and found observations that may affect product quality. The company is recalling one lot of vanilla honey flavor cough drops sold nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
QC Quality Choice menthol cough drops are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects specific lot numbers with expiration dates in May and July 2026. No injuries have been reported.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
QC Quality Choice Menthol-Cough Suppressant Oral Anesthetic Cough Drops in Honey Lemon flavor are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility in August 2025. The affected product is the 30-count bag with lot number 20240720 and expiration date 07/20/2026.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice throat drops
QC Quality Choice Pectin Oral Demulcent Throat Soothing Drops (Creamy Strawberry, 30-count) are being recalled due to manufacturing quality issues found during an FDA inspection. The recall affects lot #20240720 with an expiration date of 07/20/2026, distributed nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
The FDA inspected the manufacturing facility for QC Quality Choice Menthol-Cough Suppressant Oral Anesthetic Cough Drops on August 15, 2025, and identified quality concerns. The recall affects specific lots distributed nationwide. No injuries have been reported.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
The FDA inspected the manufacturing facility for QC Quality Choice menthol cough drops on August 15, 2025, and found quality concerns. The company is recalling cherry-flavored cough drops from two specific production batches out of an abundance of caution.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using QC Quality Choice cough drops
QC Quality Choice menthol cough drops (black cherry flavor, sugar free) are being recalled because the FDA found quality control issues during a factory inspection on August 15, 2025. The specific concern affects lot #20240720 with expiration date 07/20/2026. No injuries have been reported.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using MGC Health Menthol Cough Drops
MGC Health Menthol Cough Drops (Honey Lemon flavor, 80-count bags) are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects lot #20240730 with an expiration date of July 30, 2026, distributed nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using MGC Health cough drops
MGC Health Menthol Cough Drops (Honey Lemon flavor, 30-count bags) are being recalled after the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects products with lot number 20240524 and expiration date 05/24/2026 distributed nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using MGC Health cough drops
The FDA recommended a recall of MGC Health Menthol Cough Drops (Sugar Free, Honey Lemon) after inspecting the manufacturing facility on August 15, 2025, and identifying quality control issues. The recall affects three specific product lots distributed nationwide.
- 2026-04-22FDA-DrugKang ZhongyuanClass IINationwideStop using Discount Drug Mart cough drops
The FDA inspected the manufacturing facility for these cough drops on August 15, 2025, and found observations that may affect product quality. The affected product is a 30-count bag of Discount Drug Mart menthol cough drops (Lot #20241030, expiring 10/30/2026) distributed nationwide.
Get notified about new Minnesota recalls
Free weekly digest. Add Minnesota to your profile to filter alerts to your state.
Get the Sunday Brief